30-day average of 11 articles Β· scale β100 to +100
Across 11 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of HCA Healthcare news is Neutral (+6)
on a scale from β100 to +100.
π Management forecasts 2% to 3% full-year service volume growth for 2027.
π Q3 2026 net income reached $1.579 billion amid $400M uninsured care impact.
Slightly Bearish -15
HCA Healthcare stock faces flat 2027 outlook as payer pressure grows
AI-generated analysis
Key insights
π HCA Healthcare enters 2027 with resilient patient demand but a preliminary earnings outlook pointing to limited growth momentum.
π Management expects full-year service volume to grow by 2% to 3% in 2027 despite headwinds from payer mix changes.
πΈ The shift from exchange coverage to uninsured care reduced pre-tax income by approximately $400 million in the third quarter of 2026.
π₯ HCA reported Q3 2026 revenue of $19.849 billion and net income attributable to the company of $1.579 billion.
π Medicaid payments are expected to create a headwind, with $550 million to $650 million less in supplemental payment net benefits anticipated for 2027.
π‘οΈ The company is relying on its enterprise-wide resiliency program and digital transformation to offset reimbursement pressure.
π January earnings guidance will provide the next detailed framework for investors regarding revenue and earnings assumptions.
π HCA Healthcare stock traded at 458.05 euros on November 12, 2026, up 1.38% from the previous report.
π Bullish signals
πHCA Healthcare is entering 2027 with resilient patient demand and expects service volume to grow by 2% to 3% in the year.
π₯The company reported robust third-quarter financials with revenue of $19.849 billion and net income attributable to HCA Healthcare of $1.579 billion for the period ended September 30, 2026.
π Risk factors
πWeaker payer economics are limiting profit momentum as management expects full-year earnings to remain generally consistent with 2026 levels.
πΈThe shift from exchange coverage to uninsured care reduced income before income taxes by about $400 million during the third quarter of 2026.
πHCA expects $550 million to $650 million less in Medicaid supplemental payment net benefits in 2027 due to state programs receiving grandfathered approvals that will not repeat.
Article
HCA Healthcare is entering 2027 with resilient patient demand but faces a preliminary earnings outlook indicating limited growth momentum. Management expects full-year service volume to grow between 2% and 3%, driven by continued demand, though profit expansion is being constrained by weaker payer economics.
The company reported strong third-quarter financials with revenue of $19.849 billion and net income attributable to HCA Healthcare of $1.579 billion for the period ended September 30, 2026. However, a significant headwind emerged as the shift from exchange coverage to uninsured care reduced pre-tax income by approximately $400 million during the quarter.
Medicaid reimbursement pressures are expected to further impact 2027 performance, with HCA anticipating $550 million to $650 million less in supplemental payment net benefits compared to the prior year. This decline is attributed to state programs receiving grandfathered approvals in 2026 that will not repeat at the same level in the upcoming fiscal year.
Investors are awaiting detailed guidance from HCA Healthcare's January earnings update, which will clarify revenue and earnings assumptions for 2027. The company plans to rely on its enterprise-wide resiliency program, digital transformation initiatives, and operating leverage derived from volume growth to offset these reimbursement pressures.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
HCA Healthcare Inc. shares rallied 2.63% to $386.92 on Tuesday, marking the company's second consecutive day of gains despite a broader market decline.
The stock outperformed significantly during a dismal trading session where the S&P 500 Index fell 1.44% and the Dow Jones Industrial Average dropped slightly.
This positive momentum suggests investor confidence in HCA Healthcare relative to its peers, even as general equity markets faced downward pressure.
π HCA stock rose 2.63% to $386.92 on Tuesday.
π Shares gained for the second consecutive day.
π Market fell as S&P 500 dropped 1.44%.
π‘ HCA outperformed competitors in a dismal session.
β±οΈ Data reflects Nasdaq trades through FACTSET.
π HCA Healthcare stock rose 2.63% to close at $386.92 on Tuesday.
π This rally represents the second consecutive day of gains for the company's shares.
π The broader market was negative, with the S&P 500 falling 1.44% and the Dow Jones dropping 0.09%.
π‘ HCA outperformed competitors during an all-around dismal trading session for the stock market.
β±οΈ Intraday data provided by FACTSET reflects trades reported through Nasdaq only.
π The article was published on June 23, 2026, at 4:41 p.m. ET.
Bullish Signals
Shares rallied 2.63% to $386.92 amid S&P 500 decline.
Stock gained for second consecutive day showing strong sentiment.
Bullish Signals
HCA Healthcare shares rallied 2.63% to $386.92, demonstrating resilience and outperformance against a backdrop of a declining S&P 500.
The stock achieved its second consecutive day of gains, indicating sustained positive investor sentiment despite broader market headwinds.
The U.S. healthcare sector added 35,200 jobs in May, extending a year-long trend of robust employment growth driven by sustained demand for medical services. This expansion is led by ambulatory health services, which added 25,700 positions, and hospitals, which added 6,000. Analysts view this consistency as a signal of structural demand rather than a seasonal fluctuation, suggesting that revenue growth will follow where new jobs are being created.
Three specific stocks are positioned to capitalize on these macroeconomic trends: UnitedHealth Group (UNH), HCA Healthcare (HCA), and Encompass Health (EHC). UnitedHealth benefits from increased utilization across its insurance and Optum care delivery platforms. HCA, the largest hospital operator, sees direct revenue translation from rising inpatient and ambulatory volumes. Encompass Health targets the post-acute rehabilitation market, which is growing as patients require structured recovery before returning home.
UnitedHealth Group reported Q1 2026 revenue of $111.7 billion, a 2% year-over-year increase, with its medical benefit ratio improving to 83.9%. Management raised full-year 2026 adjusted EPS guidance to above $18.25 per share. HCA Healthcare reported Q1 2026 revenue of $19.1 billion (up 4.3%) and operating cash flow that jumped 22% to $2 billion, while deploying $1.1 billion in capital expenditures.
Encompass Health delivered its best earnings performance in recent history with Q1 2026 revenue growing 9% to $1.59 billion and adjusted EPS surging 16.8%. The company raised full-year 2026 revenue guidance to between $6.375 billion and $6.47 billion, citing an aging population and a structural shift toward higher-quality rehabilitation settings. Management is actively expanding capacity with seven new hospitals opening in 2026.
π Healthcare added 35,200 jobs in May led by ambulatory services.
πΌ UnitedHealth Group revenue hit $111.7B and raised EPS guidance.
π₯ HCA revenue rose 4.3% to $19.1B with cash flow up 22%.
π Encompass Health adjusted EPS surged 16.8% and raised revenue guidance.
π EHC expanding with seven new hospitals and lowest nurse turnover since 2012.
π Healthcare added 35,200 jobs in May, led by 25,700 in ambulatory services and 6,000 in hospitals, signaling sustained demand.
πΌ UnitedHealth Group (UNH) reported Q1 2026 revenue of $111.7 billion and raised full-year EPS guidance to above $18.25.
π₯ HCA Healthcare (HCA) achieved a 4.3% revenue increase to $19.1 billion in Q1 2026 with operating cash flow up 22%.
π Encompass Health (EHC) saw adjusted EPS surge 16.8% and raised full-year revenue guidance to $6.375-$6.47 billion.
π UNH medical benefit ratio improved to 83.9%, reflecting better cost management and normalized pressure.
ποΈ HCA deployed $1.1 billion in capital expenditures while repurchasing $1.6 billion in shares during Q1 2026.
π EHC is expanding with seven new hospitals opening in 2026 and adding 100-150 beds to existing facilities.
π₯ EHC nurse turnover hit its lowest level since 2012, providing a tangible labor cost benefit.
π° Analysts give HCA a consensus price target of $506.14, implying a potential 30% gain from current levels.
π― Encompass Health has a consensus Buy rating with a $143.86 price target suggesting over 40% upside.
Bullish Signals
Healthcare employment growth averages 38,000 new jobs monthly.
UnitedHealth Group medical benefit ratio improved to 83.9%.
HCA Healthcare operating cash flow jumped 22% to $2B.
Encompass Health revenue up 9% and EPS up 16.8%.
Encompass Health discharge-to-community rate improved to 84.5%.
HCA Healthcare investing $1.1B in Q1 capital expenditures.
Encompass Health opening seven new hospitals in 2026.
Analysts see over 40% upside potential for Encompass.
Risk Factors
UnitedHealth trades at a 22x forward earnings premium.
HCA Healthcare down over 16% in 2026.
Encompass Health down 4% in 2026.
Bullish Signals
Healthcare employment growth is consistent and structural, averaging roughly 38,000 new jobs per month over the past year.
UnitedHealth Group's medical benefit ratio improved to 83.9%, indicating better cost management and normalization of sector pressures.
HCA Healthcare operating cash flow strengthened significantly to $2 billion, a 22% jump from the prior-year quarter.
Encompass Health reported its best earnings in recent history with revenue up 9% and adjusted EPS up 16.8%.
Encompass Health's discharge-to-community rate improved by 50 basis points to 84.5%, enhancing operational efficiency.
HCA Healthcare is actively investing in capacity with $1.1 billion in Q1 capital expenditures to meet rising demand.
Encompass Health is expanding its footprint with seven new hospitals scheduled to open in 2026.
Analysts maintain a consensus Buy rating for Encompass Health with a price target implying over 40% upside potential.
Risk Factors
UnitedHealth Group is trading at a slight premium of 22x forward earnings compared to its historic average.
HCA Healthcare stock is down over 16% in 2026 and remains well below its all-time high from February.
Encompass Health stock is down about 4% in 2026 despite strong operational performance.
HCA Healthcare, Inc. (NYSE: HCA) reported quarterly earnings that slightly missed profit expectations but topped revenue estimates. The company posted $7.15 in earnings per share against a consensus of $7.19, while revenue reached $19.11 billion versus an expectation of $19.09 billion. This represents a 4.3% year-over-year increase in quarterly revenue, though the firm recorded a negative return on equity of -295.93% and a net margin of 8.89%.
Institutional ownership saw mixed activity during the fourth quarter. Arax Advisory Partners significantly reduced its stake by 40.8%, selling 3,880 shares worth approximately $2.63 million. Conversely, major institutions including State Street Corp, Capital World Investors, Geode Capital Management LLC, Norges Bank, and Arrowstreet Capital Limited Partnership increased their holdings. Overall, institutional investors and hedge funds now control 62.73% of the company's outstanding stock.
Wall Street analysts maintain a generally positive outlook despite recent price target adjustments from major banks like JPMorgan Chase and Wells Fargo. The consensus rating remains a 'Moderate Buy' with an average price target of $506.14, significantly higher than the current trading price near $387. The company has set fiscal year 2026 guidance between $29.10 and $31.50 per share, while analysts anticipate earnings of approximately $30.07 for the current year.
HCA Healthcare also announced a quarterly dividend to be paid on June 30th to shareholders of record on June 16th. The dividend amount is $0.78 per share, representing an annualized yield of 0.8% and a payout ratio of 10.73%. Founded in 1968 and headquartered in Nashville, Tennessee, the for-profit operator manages a vast network of acute care hospitals, surgical centers, and outpatient clinics across the United States.
π Arax Advisory cut HCA stake by 40.8% to 5,638 shares.
π Major institutions increased holdings during the fourth quarter.
π° Revenue hit $19.11B, slightly beating analyst estimates.
π EPS was $7.15, missing the $7.19 consensus estimate.
π― Analyst price target of $506.14 exceeds current stock price.
π Arax Advisory Partners cut its HCA Healthcare stake by 40.8% in Q4, selling 3,880 shares to reduce its position to 5,638 shares valued at $2.63 million.
π Major institutional investors including State Street Corp, Capital World Investors, and Geode Capital Management increased their holdings during the fourth quarter.
π° HCA reported quarterly revenue of $19.11 billion, slightly beating analyst estimates of $19.09 billion despite missing EPS expectations.
π The company posted $7.15 in earnings per share compared to a consensus estimate of $7.19 for the quarter ending April 24th.
π― Analysts maintain an average price target of $506.14, which is substantially higher than the stock's recent trading price around $387.
π HCA Healthcare has set fiscal year 2026 earnings guidance between $29.10 and $31.50 per share.
π΅ The company declared a quarterly dividend of $0.78 per share with an ex-dividend date of June 16th.
π₯ HCA operates a large network of acute care hospitals, surgical centers, and outpatient clinics headquartered in Nashville, Tennessee.
Bullish Signals
Revenue hit $19.11 billion, showing strong top-line growth.
P/E ratio is 13.32 with P/E/G of 1.23.
Institutional investors increased stakes in the company.
Analyst price target is $506.14, implying upside.
FY2026 EPS guidance ranges from $29.10 to $31.50.
Dividend yield stands at 0.8%.
Risk Factors
Missed EPS expectations by $0.04, reporting $7.15 vs $7.19 consensus.
Negative ROE of -295.93% signals potential capital structure concerns.
Major banks JPMorgan and Wells Fargo lowered price targets.
Institutional investor Arax reduced position by 40.8%.
Bullish Signals
HCA Healthcare topped revenue estimates with $19.11 billion in quarterly revenue, demonstrating strong top-line growth despite missing EPS targets.
The stock trades at a P/E ratio of 13.32 and a P/E/G ratio of 1.23, suggesting the market values its earnings growth potential favorably.
Major institutional investors like State Street Corp and Capital World Investors increased their stakes, indicating continued confidence in the company's long-term prospects.
Analysts maintain an average price target of $506.14, implying significant upside potential from current levels near $387.
The company has set robust fiscal year 2026 guidance ranging from $29.10 to $31.50 EPS, exceeding the average analyst expectation of $30.07.
HCA announced a quarterly dividend payment, providing income support to shareholders with an annualized yield of 0.8%.
Risk Factors
The company missed earnings per share expectations by $0.04, reporting $7.15 against a consensus of $7.19.
HCA reported a negative return on equity of -295.93%, indicating potential leverage or capital structure concerns affecting shareholder returns.
Several major banks including JPMorgan Chase and Wells Fargo recently decreased their price targets, signaling some caution among analysts.
Arax Advisory Partners significantly reduced its position by 40.8%, which may reflect a lack of confidence from this specific institutional investor.
HCA Healthcare has announced an agreement to acquire The College of Health Care Professions (CHCP), a healthcare education provider with over 8,000 students annually across 10 Texas campuses and online. The two entities have maintained a long-standing partnership through clinical sites, program advisory boards, and career placement initiatives, with this acquisition reflecting a shared commitment to academic quality and workforce readiness.
In its fiscal Q1 2026 financial results, HCA reported revenues rising 4.3% to $19.109 billion and net income increasing 0.6% to $1.620 billion. Diluted earnings per share grew 10.9% to $7.15, while cash flows from operating activities expanded 22.0% to $2.014 billion. The company operates a diverse portfolio including hospitals, urgent care facilities, surgery centers, and diagnostic imaging centers.
π₯ HCA agrees to acquire The College of Health Care Professions.
π CHCP educates 8,000+ students annually across Texas campuses online.
π Q1 2026 revenues rose 4.3% to $19.1 billion for HCA.
π° Operating cash flow expanded 22% to $2.014 billion in Q1.
β οΈ Article suggests alternative AI stocks may offer higher upside potential.
π₯ HCA Healthcare (NYSE: HCA) has announced an agreement to acquire The College of Health Care Professions (CHCP).
π CHCP provides healthcare education to over 8,000 students annually across 10 Texas campuses and online.
π€ The two entities have partnered for decades through clinical sites, advisory boards, and career placement programs.
π In fiscal Q1 2026, HCA reported revenues rising 4.3% to $19.109 billion.
π° Net income attributable to the company increased 0.6% to $1.620 billion in the same period.
π Diluted earnings per share grew 10.9% to $7.15, while adjusted EPS also rose by that margin.
π΅ Cash flows from operating activities expanded 22.0% to reach $2.014 billion.
π₯ HCA operates a diverse portfolio including hospitals, urgent care facilities, surgery centers, and imaging centers.
π The acquisition underscores a shared commitment to academic quality and workforce readiness in healthcare education.
β οΈ The article includes promotional content suggesting alternative AI stocks may offer higher upside potential than HCA.
π° Additional links within the text reference various stock lists, earnings call transcripts, and investment strategies.
Bullish Signals
Acquires CHCP for shared commitment to academic quality and student success.
Expands educational footprint serving 8,000+ students across 10 Texas campuses.
Fiscal Q1 2026 revenues rose 4.3% to $19.109 billion.
Net income grew 0.6% to $1.620 billion; EPS up 10.9% to $7.15.
Operating cash flows surged 22.0% to $2.014 billion.
Risk Factors
Author favors AI stocks over HCA for higher returns in shorter time.
Text suggests checking other reports for cheaper AI stocks with better upside.
Bullish Signals
HCA Healthcare announced an agreement to acquire The College of Health Care Professions (CHCP), highlighting a shared commitment to academic quality, student success, and workforce readiness.
The acquisition expands HCA's educational footprint by providing healthcare education to more than 8,000 students per year across 10 campuses throughout Texas and online.
In fiscal Q1 2026, HCA Healthcare reported that revenues rose 4.3% to $19.109 billion, demonstrating strong top-line growth.
Net income attributable to the company increased 0.6% to $1.620 billion, while diluted earnings per share grew 10.9 percent to $7.15 per diluted share.
Cash flows from operating activities surged 22.0% to $2.014 billion, indicating robust cash generation capabilities.
Risk Factors
The article explicitly states that while acknowledging the risk and potential of HCA, the author's conviction lies in AI stocks holding greater promise for delivering higher returns within a shorter time frame.
The text suggests that if an investor is looking for an AI stock with more promising upside potential than HCA, they should check out another report about a different 'cheapest AI stock'.
On June 8, HCA Healthcare Foundation awarded a $25,000 grant to Tri-County STEMersion to support immersive, hands-on professional development for STEM educators across Berkeley, Charleston, and Dorchester counties in the Lowcountry region. The funding aims to help teachers develop classroom experiences that connect students to careers in healthcare, science, technology, and engineering, with more than 150 STEM educators participating in the program this year. At a ceremony held at the Lowcountry Conference Center, educators from multiple school districts celebrated the grant and expressed excitement about attending the upcoming week-long STEMersion event.
Jeff Wilson, president of HCA Healthcare Charleston and CEO for HCA Healthcare Trident Hospital, emphasized that investing in educators and innovative learning experiences helps build a stronger pipeline of future clinicians, scientists, and engineers to improve community health. He noted that while their mission starts with patient care, it extends into the community through education and workforce development, ultimately investing in students to support the future healthcare workforce and community prosperity.
The article also highlights HCA Healthcare's broader community impact, noting that in 2024 the company provided charity care, uninsured discounts, and other uncompensated services at an estimated cost of $4.4 billion, while contributing more than $48.5 million to community organizations. Additionally, Fort Dorchester High School teacher Krista Martin received the Jostens Renaissance National Staffulty Member of the Month Award, reflecting the positive school culture that Wilson described as welcoming and supportive.
π HCA awarded $25,000 to Tri-County STEMersion for professional development.
π Funding supports immersive healthcare and STEM career learning experiences.
π₯ Over 150 educators collaborate with industry leaders on lesson plans.
π° HCA provided $4.4B in charity care and $48.5M in grants.
π« Teacher Krista Martin won a national staff member award.
π On June 8, HCA Healthcare Foundation awarded a $25,000 grant to Tri-County STEMersion for professional development in Berkeley, Charleston, and Dorchester counties.
π The funding supports immersive, hands-on learning experiences connecting students to careers in healthcare, science, technology, and engineering.
π₯ More than 150 STEM educators are participating in the program this year to develop lesson plans with industry leaders.
π€ Jeff Wilson, president of HCA Healthcare Charleston, stated that investing in education builds a pipeline for future clinicians and scientists.
π° In 2024, HCA Healthcare provided an estimated $4.4 billion in charity care and uncompensated services to the community.
π€² The company also contributed over $48.5 million to community organizations in 2024 to support workforce development.
π« Krista Martin from Fort Dorchester High School received the Jostens Renaissance National Staffulty Member of the Month Award.
HCA awarded $25,000 grant to Tri-County STEMersion on June 8.
Over 150 STEM teachers collaborated with industry leaders in 2025.
HCA provided $4.4 billion charity care and $48.5M community contributions in 2024.
Fort Dorchester teacher Krista Martin won Jostens Renaissance National Staffulty Award.
STEMersion connects students to healthcare careers through hands-on industry experiences.
Risk Factors
Company spent >$48.5M on non-operating community contributions in 2024.
Bullish Signals
HCA Healthcare Foundation awarded a $25,000 grant to Tri-County STEMersion on June 8 to support immersive professional development for STEM educators across Berkeley, Charleston, and Dorchester counties.
More than 150 STEM teachers collaborated with industry leaders in 2025 to develop lesson plans for the upcoming school year, fostering a stronger pipeline of future clinicians, scientists, and engineers.
In 2024, HCA Healthcare provided charity care and uncompensated services at an estimated cost of $4.4 billion, demonstrating significant commitment to community health and accessibility.
HCA Healthcare contributed more than $48.5 million to community organizations in 2024, extending its mission beyond hospital walls to support broader community prosperity.
Fort Dorchester High School teacher Krista Martin received the Jostens Renaissance National Staffulty Member of the Month Award, highlighting the school's supportive culture and excellence in education.
Jeff Wilson, president of HCA Healthcare Charleston and CEO for HCA Healthcare Trident Hospital, emphasized that investing in students directly invests in the future healthcare workforce.
The STEMersion program connects students to careers in healthcare, science, technology, and engineering through hands-on classroom experiences developed with industry leaders.
Educators across multiple school districts expressed excitement about attending the week-long STEMersion, indicating strong engagement and positive reception of the initiative.
HCA Healthcare's investment in education and workforce development aligns with its mission to care for and improve human life by supporting community prosperity.
The grant supports immersive learning experiences that help build a stronger pipeline of future professionals who will improve community health for years to come.
Risk Factors
The company contributed more than $48.5 million to community organizations in 2024, further indicating substantial non-operating expenditures.
HCA Healthcare, a Nashville-based provider with 189 hospitals and approximately 2,600 ambulatory sites, has agreed to acquire the College of Health Care Professions (CHCP). CHCP is a Houston-based organization that provides healthcare education to over 8,000 students annually across 10 Texas campuses and online. Since its founding in 1988, CHCP has graduated more than 52,000 students into healthcare careers.
The acquisition builds upon a long-standing partnership between the two entities that includes program advisory boards, clinical site usage, and career placement services. Notably, in 2023, HCA collaborated with CHCP to launch a 12-week Medical Assistant training program designed to upskill employees for urgent care centers across Texas. To date, over 100 employees have successfully completed this program, enhancing their internal career opportunities.
CHCP offers more than 20 accredited programs, including Medical Assisting, Sonography, Surgical Technology, Radiologic Technology, and Medical Coding and Billing, with flexible hybrid and online options. Sam Hazen, CEO of HCA Healthcare, stated that the acquisition strengthens the talent pipeline serving patients and communities. This move aligns with HCA's broader strategy of investing in workforce development, evidenced by its majority ownership of Galen College of Nursing since 2020 and recent grants to educational foundations.
The transaction is subject to regulatory approval and customary closing conditions, with financial terms undisclosed. Eric Bing, Chancellor and CEO of CHCP, expressed excitement about the partnership's shared commitment to adult learner success and workforce readiness. HCA has a history of supporting education initiatives, including launching Pepperdine University's School of Nursing in 2025 and providing multi-million dollar grants to Educate Texas and the Consortium of Florida Education Foundations.
π₯ HCA acquires College of Health Care Professions to expand education portfolio.
π CHCP serves 8,000 students annually across 10 Texas campuses and online.
πΌ Successful 12-week Medical Assistant program graduated over 100 employees in 2023.
π Offers 20+ accredited programs including Sonography, Surgical Tech, and Medical Coding.
βοΈ Transaction pending regulatory approval with undisclosed financial terms.
π₯ HCA Healthcare is acquiring Houston-based College of Health Care Professions (CHCP) to expand its healthcare education portfolio.
π CHCP serves over 8,000 students annually across 10 Texas campuses and online, having graduated more than 52,000 students since 1988.
π€ The deal leverages a decades-long partnership involving program advisory boards, clinical sites, and career placement services.
πΌ In 2023, HCA and CHCP launched a successful 12-week Medical Assistant training program that has already graduated over 100 employees.
π CHCP offers over 20 accredited programs including Medical Assisting, Sonography, Surgical Technology, Radiologic Technology, and Medical Coding.
π HCA operates 189 hospitals and approximately 2,600 ambulatory sites of care across the United States.
π This acquisition follows HCA's 2020 majority ownership of Galen College of Nursing and expansion to 25 campuses nationwide.
π€ In 2025, HCA helped launch Pepperdine University's School of Nursing within the College of Health Sciences.
π° HCA has committed significant funding to workforce development, including $1.35 million and $1 million grants to Educate Texas.
βοΈ The transaction is pending regulatory approval and customary closing conditions with undisclosed financial terms.
Bullish Signals
Acquires major education provider to ensure steady skilled professional flow.
Joint Medical Assistant program graduated over 100 employees immediately.
Brings over 20 accredited programs in high-demand fields like Sonography.
Reinforces commitment to value-based care and workforce development trends.
Proven track record integrating educational institutions like Galen College.
Bullish Signals
HCA Healthcare is strengthening its talent pipeline by acquiring a major healthcare education provider, ensuring a steady flow of skilled professionals for its urgent care centers and hospitals.
The acquisition expands HCA's existing successful model of workforce development, evidenced by the immediate success of their joint Medical Assistant training program which graduated over 100 employees.
CHCP brings a robust portfolio of over 20 accredited programs to HCA, diversifying its educational offerings in high-demand fields like Sonography and Surgical Technology.
The deal reinforces HCA's strategic commitment to value-based care and workforce development, aligning with industry trends that prioritize upskilling employees for evolving healthcare needs.
HCA's history of successful education acquisitions, such as Galen College of Nursing, suggests a proven track record in integrating educational institutions into its operational ecosystem.
HCA Healthcare Inc. reported first-quarter 2026 financial results showing revenue of $19.109 billion, representing a 4.3% year-over-year increase. Net income rose slightly to $1.620 billion, while diluted earnings per share grew by 10.9% to $7.15. Adjusted EBITDA reached $3.802 billion, up 1.9%, and cash flows from operating activities increased significantly by 22% to $2.014 billion.
Operational performance included a 0.9% increase in same-facility admissions and a 1.3% rise in equivalent admissions, though the company noted an absence of typical seasonal volume growth due to a 42% decline in respiratory-related admissions and severe winter storms in January. Same-facility inpatient and outpatient surgeries also saw slight declines compared to Q1 2025. CEO Sam Hazen credited staff adaptation to these conditions, while unfavorable impacts on patient volumes were largely mitigated by the recognition of specific Medicaid supplemental programs not accounted for in initial 2026 financial guidance.
HCA Healthcare operates as a leading American for-profit company providing healthcare services through 186 hospitals and approximately 2,400 sites of care across 20 states and the UK. The article includes promotional content about AI stocks and subscription offers, but the core reporting on HCA's financial performance and operational metrics remains substantive.
π Q1 2026 revenue hit $19.1B, up 4.3% year-over-year.
π° Net income reached $1.62B with EPS growing 10.9%.
β οΈ Respiratory admissions dropped 42% due to winter storms.
π₯ HCA operates 186 hospitals across 20 states and the UK.
π Analysts view HCA as undervalued despite AI stock promotion.
π HCA Healthcare reported Q1 2026 revenue of $19.109 billion, representing a 4.3% year-over-year increase.
π° Net income rose to $1.620 billion while diluted earnings per share grew by 10.9% to $7.15.
π Adjusted EBITDA reached $3.802 billion, reflecting a 1.9% increase from the prior year period.
π΅ Cash flows from operating activities saw a significant rise of 22% to $2.014 billion.
π₯ Same-facility admissions increased by 0.9%, while equivalent admissions rose by 1.3%.
β οΈ Respiratory-related admissions declined by 42%, impacting overall patient volume growth for the quarter.
βοΈ Severe winter storms in January contributed to lower-than-typical seasonal volume growth.
πͺ Same-facility inpatient and outpatient surgeries saw slight declines compared to Q1 2025.
π¨βπΌ CEO Sam Hazen credited staff adaptation for navigating the changing operational conditions.
π Unfavorable patient volume impacts were mitigated by recognizing specific Medicaid supplemental programs not in initial guidance.
π’ HCA operates through 186 hospitals and approximately 2,400 sites of care across 20 states and the UK.
π Analysts consider HCA one of the most undervalued large cap stocks to buy currently.
π€ The article includes a promotional note suggesting AI stocks may offer higher returns than HCA.
π Readers are directed to additional reports on other stocks like Clearway Energy and Nextpower.
Analysts view HCA as an undervalued large cap buy.
Risk Factors
Surgeries declined vs Q1 2025.
Seasonal growth absent due to 42% respiratory drop.
Winter storms impacted January volume.
Bullish Signals
HCA Healthcare reported Q1 2026 revenues of $19.109 billion, representing a 4.3% year-over-year increase.
Net income grew to $1.620 billion while diluted EPS increased by 10.9% to $7.15.
Cash flows from operating activities saw a significant rise of 22% to $2.014 billion, reflecting strong operational efficiency.
The company recognized specific Medicaid supplemental programs that were not in the initial guidance, effectively mitigating unfavorable impacts on patient volumes.
Analysts consider HCA Healthcare one of the most undervalued large cap stocks to buy.
Risk Factors
Same-facility inpatient and outpatient surgeries saw slight declines compared to Q1 2025.
Typical seasonal volume growth was absent, primarily driven by a 42% decline in respiratory-related admissions and the impact of severe winter storms in January.
HCA Healthcare is breaking ground on a new freestanding emergency room in Cane Bay, scheduled to open in spring 2027. The $15 million facility will span 10,000 square feet and feature 10 patient exam rooms, a triage room, advanced imaging services, laboratory capabilities, and telemedicine support for stroke and behavioral health care. Located at 1866 State Road, the ER is designed to serve the Cane Bay, Nexton, Del Webb, Carnes Crossroads, and surrounding communities in the Lowcountry region.
The project addresses growing community needs, with HCA noting that over 350,000 patients received emergency care at its Lowcountry facilities in 2025. Local leaders emphasize the importance of reduced transport times for faster response and better patient outcomes. The Cane Bay ER will be the third freestanding ER groundbreaking by HCA Healthcare this year across Charleston, following plans to open additional facilities on Johns Island and Long Point in the near future.
ποΈ HCA breaks ground on a $15M ER opening spring 2027.
π The 10,000 sq ft site includes imaging, labs, and telemedicine.
π Shorter drives will save lives and enable advanced pre-hospital care.
ποΈ HCA Healthcare broke ground on a new emergency room at Cane Bay on May 26, serving multiple surrounding communities.
π The facility is scheduled to open in spring 2027 and will cost $15 million to build.
π The 10,000-square-foot ER will feature 10 patient exam rooms, a triage room, advanced imaging, and laboratory services.
π§ Telemedicine capabilities for stroke and behavioral health care will be integrated into the new facility.
π In 2025, over 350,000 patients received emergency care at HCA Healthcare facilities in the Lowcountry region.
π― ER Medical Director Neal Shelley stated that every decision for this project was guided by strengthening community health and safety.
π₯ The new facility aims to ensure emergency care is never out of reach for anyone in the evolving region.
Bullish Signals
$15M HCA Cane Bay ER serves multiple communities.
Spring 2027 opening includes imaging, lab, and telemedicine.
Third Charleston freestanding ER groundbreaking this year.
HCA served 350k+ patients in Lowcountry emergency care.
Shorter ambulance transport times improve response speeds.
Bullish Signals
The $15 million, 10,000-square-foot HCA Healthcare Cane Bay ER will serve multiple communities including Cane Bay, Nexton, Del Webb, and Carnes Crossroads.
Once open in spring 2027, the facility will feature advanced capabilities such as imaging services, laboratory services, and telemedicine for stroke and behavioral health care.
The new ER is the third freestanding ER groundbreaking this year across Charleston, with additional facilities at Johns Island and Long Point opening in the near future.
HCA Healthcare already served more than 350,000 patients in emergency care at Lowcountry facilities in 2025, demonstrating strong regional demand.
The new location will enable shorter transport times for ambulances, allowing EMS to keep vehicles closer to communities and improve response speeds.
Advanced pre-hospital care combined with expanded ER access is expected to result in better outcomes, faster treatment, less pain, and more lives saved.
The project represents a significant investment aimed at strengthening the long-term health, safety, and well-being of the community for current and future generations.
HCA Healthcare has acquired 17 urgent care clinics from Urgent Care Group to expand its access to care in the Carolinas. The new locations include sites in Charleston, Columbia, Myrtle Beach, and Spartanburg in South Carolina, as well as one in Wilmington, North Carolina. Following the acquisition, the South Carolina facilities will operate under the HCA CareNow brand, marking the first time this urgent care network has been established in the state. In contrast, the North Carolina clinic will continue to use the Medac name previously associated with Urgent Care Group.
This strategic investment is part of a broader initiative by HCA Healthcare to consolidate more healthcare sites under its own brand within South Carolina, aiming to simplify patient access and create a connected network of services. Over the past five years, HCA has invested more than $800 million in South Carolina to support healthcare infrastructure, technology, and expanded care access. The acquisition strengthens HCA's existing footprint in the region, which already includes four acute care hospitals, a behavioral health hospital, over 40 physician practice locations, eight freestanding emergency rooms, and more than 21 urgent care clinics statewide.
In the Myrtle Beach area specifically, the new clinics will integrate with Grand Strand Healthβs comprehensive network, providing patients with seamless access to primary care, specialty services, emergency care, and hospital-based treatment. Dr. John Lazenby, Chief Medical Officer for HCA Healthcare's South Atlantic Division, stated that this investment helps improve lives by expanding access to convenient, high-quality healthcare for unexpected, non-emergency needs. Matt Kossman, CEO of Urgent Care Group, expressed pride in the care delivered by their teams and excitement about the clinics continuing to grow within HCA Healthcare's network.
π₯ HCA acquired 17 urgent care clinics in South Carolina and North Carolina.
π° This deal follows over $800 million invested in South Carolina recently.
π SC sites launch as HCA CareNow, while NC locations keep the Medac name.
π₯ HCA Healthcare acquired 17 urgent care clinics from Urgent Care Group to expand patient access in the Carolinas.
π The new locations include sites in Charleston, Columbia, Myrtle Beach, and Spartanburg in South Carolina plus Wilmington in North Carolina.
π° The acquisition is part of a broader investment strategy where HCA has spent over $800 million in South Carolina over the last five years.
π·οΈ South Carolina clinics will operate under the new HCA CareNow brand, becoming the first of their kind in the state.
π North Carolina locations will continue operating under the existing Medac name used by Urgent Care Group.
π¨ββοΈ Dr. John Lazenby stated the investment aims to improve lives by providing convenient, high-quality healthcare services.
π The clinics are designed to offer timely care for unexpected, non-emergency medical needs.
π€ Matt Kossman, CEO of Urgent Care Group, expressed pride in the teams and excitement about their continued growth within HCA's network.
ποΈ This acquisition strengthens HCA's presence in South Carolina, which already includes four acute care hospitals and 40-plus physician practices.
π In Myrtle Beach, the new clinics connect patients to Grand Strand Healthβs comprehensive network of primary, specialty, and emergency services.
π The expanded network now totals more than 75 care sites statewide across South Carolina.
Bullish Signals
HCA acquired 17 urgent care clinics across South Carolina.
Investment exceeds $800 million in SC healthcare infrastructure over five years.
New sites operate as HCA CareNow, the first in the state.
Acquisition connects Myrtle Beach patients to Grand Strand Health network.
Expansion improves access to convenient, high-quality urgent care services.
Bullish Signals
HCA Healthcare has expanded access to care by acquiring 17 urgent care clinics in the Carolinas, including locations in Charleston, Columbia, Myrtle Beach, Spartanburg, and Wilmington.
The acquisition strengthens HCA's presence in South Carolina, complementing a network that includes four acute care hospitals, a behavioral health hospital, 40-plus physician practice locations, eight freestanding ERs, and more than 75 care sites statewide.
HCA Healthcare has invested more than $800 million across South Carolina over the last five years to support healthcare infrastructure, technology, and expanded access to care.
The new clinics will operate as HCA CareNow in South Carolina, becoming the first HCA CareNow urgent care clinics in the state and uniting more sites under the HCA Healthcare brand.
In the Myrtle Beach region, the acquisition connects patients to Grand Strand Health's comprehensive network of care, including primary care, specialty care, emergency services, and hospital-based care.
The investment helps improve lives by expanding access to convenient, high-quality healthcare services in the communities served.
Urgent care clinics provide timely care for unexpected, non-emergency medical needs, addressing a critical gap in patient access.
HCA Healthcare has agreed to acquire The College of Health Care Professions (CHCP), a move that expands its portfolio of healthcare education initiatives beyond its existing majority stake in Galen College of Nursing and operations at the Research College of Nursing in Kansas City and HCA Florida Mercy College of Nursing in Miami. The acquisition targets CHCP, which delivers virtual and Texas-based healthcare training to over 8,000 students annually, building on a decades-long partnership between the two entities. Financial terms for the deal were not disclosed, but Eric Bing, who currently serves as both Chancellor and CEO of CHCP, will continue to lead the organization following the transaction.
The strategic rationale centers on HCA's goal to enhance adult learner success, academic excellence, and workforce readiness, aiming to increase opportunities for aspiring healthcare professionals while making a positive impact in communities nationwide. This acquisition aligns with HCA's broader strategy of funding and acquiring healthcare-education initiatives, further solidifying its presence in the nursing and allied health education sector through its existing investments in Pepperdine University's School of Nursing and other regional colleges.
π₯ HCA acquires CHCP to expand healthcare training for 8,000+ students.
πΌ Financial terms undisclosed; Eric Bing remains Chancellor and CEO.
π₯ HCA Healthcare has agreed to acquire The College of Health Care Professions (CHCP).
π CHCP provides healthcare training both virtually and in Texas to over 8,000 students annually.
πΌ Financial terms of the acquisition were not disclosed by either party.
π€ Eric Bing, current Chancellor and CEO of CHCP, will continue to lead the organization post-acquisition.
π€ The deal expands on a decades-long partnership between HCA Healthcare and CHCP.
π― Bing stated the goal is to increase opportunities for aspiring healthcare professionals and impact communities.
π« HCA already holds a majority stake in Galen College of Nursing.
π HCA operates the Research College of Nursing in Kansas City, Missouri.
π΄ HCA operates the Florida Mercy College of Nursing in Miami.
π HCA helped launch Pepperdine University's School of Nursing.
π This acquisition continues HCA's record of acquiring or funding healthcare-education initiatives.
Bullish Signals
HCA acquires CHCP to expand healthcare education portfolio.
Decades-long partnership reinforces commitment to adult learner success.
CHCP serves 8,000+ students annually via virtual and in-person programs.
Eric Bing continues as CHCP Chancellor ensuring stability.
HCA holds majority stake in Galen College of Nursing.
Bullish Signals
HCA Healthcare agreed to acquire The College of Health Care Professions (CHCP), expanding its portfolio of healthcare-education initiatives.
The acquisition builds on a decades-long partnership between CHCP and HCA, reinforcing their shared commitment to adult learner success and workforce readiness.
CHCP serves more than 8,000 students annually through virtual and in-person programs in Texas, providing significant scale for the combined entity.
Eric Bing, CHCP's Chancellor and CEO, will continue to lead the organization post-acquisition, ensuring operational stability and continuity.
HCA already holds a majority stake in Galen College of Nursing and operates Research College of Nursing in Kansas City and HCA Florida Mercy College of Nursing in Miami, demonstrating a strong track record in healthcare education.
The deal aligns with HCA's history of acquiring or funding healthcare-education initiatives, signaling strategic growth in the training sector.
The article identifies HCA Healthcare (NYSE: HCA) as a defensive stock suitable for investors preparing for a potential market crash in 2026, alongside Microsoft. It argues that healthcare demand remains stable during economic downturns because patients continue to require medical services regardless of market conditions, and much of the revenue comes from third-party payers rather than direct patient payments. The piece highlights HCA's position as a leader in the U.S. healthcare facility network and notes its history of growth driven by technological investments and acquisitions over the past 15 years.
The text outlines three long-term drivers for increased spending in the healthcare sector: medical breakthroughs that enable treatment of previously untreatable diseases, an aging global population requiring more care, and HCA's proven strategy of investing in technology to improve patient outcomes and expand market share. The author concludes that a market crash would not alter these growth prospects, making HCA a strong buy for investors seeking stability and long-term performance during bear markets.
π Equities narrowly avoided a 2025 bear market but face recession risks in 2026.
π‘οΈ Microsoft and HCA Healthcare are top defensive picks for surviving potential downturns.
π Stock Advisor's strategy has delivered 974% average returns, outperforming the S&P 500.
π Broader equities narrowly escaped a bear market in 2025, but macroeconomic concerns could lead to a recession or crash in 2026.
πΌ Investors are advised to prepare for downturns by buying companies that can survive and perform well long after the event.
π₯ HCA Healthcare is highlighted as a defensive stock because healthcare demand remains stable regardless of market conditions.
π‘οΈ Microsoft is considered one of the most defensive tech stocks due to high switching costs and reliance on its products by millions.
π° Microsoft holds the highest credit rating available, even higher than that of the U.S. government, ensuring it can meet obligations during downturns.
βοΈ Microsoft's leadership in cloud computing and artificial intelligence provides significant long-term growth potential despite cyclical slowdowns.
π Historical data shows investing in Microsoft during market crashes has yielded above-average returns since the 2020 bear market bottomed out.
π΅ HCA Healthcare benefits from rising demand driven by technological breakthroughs, improved treatment outcomes, and an aging population.
π A significant portion of HCA's revenue comes from third-party payers rather than direct patient payments, stabilizing financial results during recessions.
π₯ HCA has grown its market share over the past 15 years through heavy investment in technology to improve patient outcomes.
π The Motley Fool Stock Advisor team identifies Microsoft as one of two great candidates for investors if a market crash occurs in 2026.
π Netflix and Nvidia are cited as examples of stocks that produced monster returns after being recommended by the Stock Advisor team in previous years.
π Stock Advisor's total average return is reported at 974%, significantly outperforming the S&P 500's 196% return over the same period.
β οΈ The Motley Fool has positions in and recommends Microsoft, while also recommending specific options on Microsoft stock.
π₯ The Motley Fool also recommends HCA Healthcare as a strong buy for investors looking to weather potential market turbulence.
π Stock Advisor returns cited in the article are as of January 9, 2026.
π€ Prosper Junior Bakiny has no position in any of the stocks mentioned in the article.
π The Motley Fool adheres to a specific disclosure policy regarding its positions and recommendations.
Bullish Signals
Defensive healthcare model navigates market downturns effectively.
Stable medical demand ensures consistent revenue during recessions.
Third-party payers maintain financial stability for HCA.
Tech breakthroughs drive long-term growth and untreatable disease treatment.
Aging population boosts healthcare spending and demand.
Heavy tech investment improved outcomes and market share.
Horizon growth unlikely affected by potential market crash.
Bullish Signals
HCA Healthcare can navigate market downturns effectively due to the defensive nature of its healthcare business model.
Demand for medical services remains stable regardless of market conditions, ensuring consistent revenue and earnings even during recessions.
Third-party payers, including private and government entities, cover a significant portion of costs, allowing HCA Healthcare to maintain financial stability.
Long-term growth is expected to be driven by technological and medical breakthroughs that enable treatment of previously untreatable diseases.
The aging global population will lead to increased demand for medical care and higher spending in the healthcare sector.
HCA Healthcare has invested heavily in acquiring best-in-class technology to improve patient outcomes, helping it grow its market share over the past 15 years.
The company still has plenty of growth on the horizon that is unlikely to be affected by a potential market crash.
Deutsche Bank has adjusted its price target for HCA Healthcare (HCA) to $540, down from a previous estimate of $558. Despite this reduction in valuation expectation, the firm maintains its "Buy" rating on the stock. In broader market context, HCA currently holds an average analyst rating of overweight with a mean price target of approximately $516.55. The adjustment reflects Deutsche Bank's specific outlook for the company while acknowledging its continued positive stance relative to other coverage.
The article notes that access to more detailed analysis or premium news regarding this announcement requires a Silver or Gold subscription plan on the platform, which is indicated in the provided text as an access barrier rather than content within the free summary view. No specific financial data, earnings reports, or operational details regarding HCA's performance are included in the visible text beyond the analyst action and price targets.
The news snippet also displays general market trends from Yahoo Finance on April 28, 2026, listing various trending tickers such as Bitcoin, Berkshire Hathaway, and GameStop, alongside top gainers like Atlassian Corporation and top losers including Summit Therapeutics. While these market movements are displayed in the article's footer section, they are not directly tied to the HCA-specific news in the provided text content.
π Deutsche Bank lowered HCA price target to $540 due to profit concerns.
π₯ Analyst consensus remains Buy but ratings have shifted to overweight overall.
βοΈ Management praised for execution despite the 7.3% operating profit cut projection.
π Deutsche Bank reduced its price target for HCA Healthcare from $558 to $540.
π Despite the downgrade, Deutsche Bank maintains a Buy rating on the stock.
π€ The adjustment reflects concerns over a 7.3% cut in operating profit for 2026.
βοΈ Management still receives credit for strong execution and effective cost management.
π HCA Healthcare currently carries an average analyst price target of $516.55.
π₯ The stock has fallen to an overweight rating consensus from the analyst community.
π This news was published on April 28, 2026, amidst broader market volatility.
Bullish Signals
Deutsche Bank maintains a Buy rating on HCA Healthcare despite cutting the price target, signaling confidence in the company's long-term fundamentals.
The stock still holds an average analyst rating of overweight with a mean price target of $516.55, indicating continued institutional interest.
Risk Factors
Deutsche Bank adjusted HCA Healthcare's price target downward to $540 from $558, indicating negative analyst sentiment despite maintaining a buy rating.
The stock is currently trading at a -0.31% daily decline, reflecting immediate market pressure on the healthcare sector.
HCA Healthcare, Inc. successfully concluded its Annual Meeting of Stockholders on April 23, 2026, with over 209 million shares represented either in person or by proxy. During the meeting, stockholders elected nine director nominees to one-year terms, effectively reaffirming the current board leadership and governance structure. Additionally, investors ratified Ernst & Young LLP as the independent auditor for fiscal year 2026 and approved a non-binding advisory vote regarding named executive officer compensation. The voting results indicated continued support for management's existing practices, as two specific stockholder proposalsβone requesting a report on healthcare consequences and another seeking to allow action by written consentβwere both rejected.
From an analyst perspective, the most recent rating for HCA Healthcare (NASDAQ: HCA) is a "Buy" with a price target set at $500.00. However, Spark's AI Analyst assigns a "Neutral" score to the stock, noting that this assessment is largely due to weak technical indicators, such as the trading price being below key moving averages, and persistent negative equity representing balance-sheet risk. Despite these concerns, positive factors driving the neutral stance include resilient operating performance, strong cash generation capabilities, and a constructive earnings update with reaffirmed guidance. This optimistic outlook exists even in the face of meaningful headwinds related to exchange rates, profit margins, and volumes.
HCA Healthcare remains a significant U.S.-based healthcare services provider that manages hospitals, freestanding surgery centers, and related facilities across multiple regional markets. The company serves a wide demographic of patients and engages extensively with various stakeholders, including public and private payers, physicians, and other entities within the healthcare sector. While the article also briefly mentions unrelated market news regarding Paramount Skydance, Ford recalls, and Intel, the core focus remains on the reaffirmation of HCA's governance framework and the mixed but cautiously optimistic financial outlook provided by analysts who balance structural risks against operational strength.
π 209 million shares voted at the April 23, 2026 annual meeting.
β Board directors and auditor ratified, though two shareholder proposals failed.
π° Analysts rate HCA Buy versus Spark AI's Neutral outlook on risks.
π₯ Resilient cash flow supports U.S. acute care hospital operations nationwide.
π HCA Healthcare held its Annual Meeting of Stockholders on April 23, 2026, with over 209 million shares represented.
π₯ Shareholders elected nine director nominees to one-year terms, reaffirming the existing board leadership and governance structure.
π§Ύ Investors ratified Ernst & Young LLP as the independent auditor for fiscal year 2026.
πΌ Stockholders approved a non-binding advisory vote on named executive officer compensation.
β Two stockholder proposals were rejected: one seeking a report on healthcare consequences and another to allow action by written consent.
π― The current analyst rating for HCA is a Buy with a $500.00 price target according to recent data.
βοΈ Spark's AI Analyst rates HCA as Neutral due to weak technicals, balance-sheet risk, and negative momentum.
π° Positive factors offsetting risks include resilient operating performance, strong cash generation, and reaffirmed earnings guidance despite headwinds.
π₯ HCA operates hospitals, freestanding surgery centers, and related facilities primarily in the U.S. acute care market.
π€ The company serves patients across multiple regional markets while engaging with public and private payers and healthcare stakeholders.
Bullish Signals
HCA Annual Meeting saw 209 million shares represented.
Stockholders elected nine directors with renewed leadership confidence.
Investors ratified Ernst & Young as independent auditor for 2026.
Analysts rate HCA as Buy with $500 price target.
Resilient cash generation offsets exchange and margin headwinds.
Risk Factors
Stock trades below moving averages with negative momentum.
Company faces persistent balance-sheet risk due to negative equity.
Headwinds from rates, margins, and volume hamper performance.
Analysts hold Neutral rating citing technical and financial risks.
HCA Healthcare held its Annual Meeting of Stockholders on April 23, 2026, with over 209 million shares represented in person or by proxy, indicating strong stockholder participation and support.
Stockholders elected nine director nominees to one-year terms and reaffirmed the existing leadership slate and governance structure, demonstrating confidence in the company's management team.
Investors ratified Ernst & Young LLP as the independent auditor for 2026, maintaining a reputable long-term financial oversight partner.
HCA received the most recent analyst rating of Buy with a $500.00 price target from Wall Street analysts.
The company's resilient operating performance and cash generation are offsetting headwinds such as exchange rate fluctuations, margin pressure, and volume declines.
Management reaffirmed its full-year guidance despite meaningful market challenges, signaling confidence in the business outlook.
Risk Factors
The stock price is trading below key moving averages, indicating very weak technicals and negative momentum.
The company faces persistent balance-sheet risk characterized by negative equity.
Operating performance and cash generation are facing meaningful headwinds from exchange rates, margin compression, and volume declines despite resilient underlying metrics.
Analyst sentiment is Neutral, holding back a recent Buy rating due to the aforementioned technical and financial risks.
Stockholders rejected two proposals related to healthcare consequences and written consent actions, which some investors may view as insufficient attention to broader societal impacts or governance flexibility.
On April 27, 2026, HCA Healthcare announced that its subsidiary HCA Inc. launched a proposed public offering of senior unsecured notes to refinance existing debt. The transaction is led by a syndicate including Citigroup, Barclays, BofA Securities, and J.P. Morgan under an effective shelf registration, with final terms pending market pricing. Proceeds will fund general corporate purposes, potentially repay borrowings under its $4 billion commercial paper program, and redeem $2.5 billion of senior notes maturing in June and September 2026. HCA Inc. simultaneously elected to redeem these specific notes on May 27, 2026, contingent on receiving net proceeds from the new offering. This strategic move aims to proactively manage near-term maturities and optimize the company's capital structure while maintaining access to capital markets for ongoing funding needs.
* Source/Context: The text includes a disclaimer ("The Globe and Mail has not reviewed this content"), promotional text for TipRanks ("Unlock hedge fund-level data..."), and some unrelated headlines at the end ("Why Oklo Stock Tumbled Today...", "Alleged Avatar Movie Leaker Arrested...").
* Core Information: HCA Healthcare (HCA) subsidiary HCA Inc. launched a proposed public offering of senior unsecured notes on April 27, 2026. Proceeds for general corporate purposes, repaying borrowings under $4 billion commercial paper program, and redeeming $2.5 billion of senior notes maturing in June/Sept 2026.
HCA Healthcare reported robust financial results for the first quarter of 2026, with revenue reaching $19.109 billion, representing a 4.3% increase from the same period last year. Net income attributable to the company grew to $1.620 billion, while diluted earnings per share rose significantly by 10.9% to $7.15. Adjusted EBITDA increased modestly by 1.9% to $3.802 billion, and cash flow from operating activities saw a substantial jump of 22.0% to $2.014 billion. Despite these overall gains, procedure volumes showed weakness with inpatient surgeries down slightly and outpatient surgeries falling 1.7%.
Operational volumes faced specific headwinds due to external factors, with respiratory-related admissions dropping 42% and emergency room visits for similar issues declining 32%, partly attributed to a January winter storm affecting some markets. However, the company offset some of this volume pressure by recognizing Medicaid supplemental programs not included in its initial guidance. Revenue per equivalent admission improved by 3.1%, indicating successful price or mix strategies despite lower admission volumes in certain categories.
Regarding capital management and shareholder returns, HCA ended the quarter with $940 million in cash and debt levels stood at $48.023 billion against total assets of $61.450 billion. The company invested $1.119 billion in capital expenditures excluding acquisitions and utilized $1.571 billion for share repurchases, leaving $9.179 billion remaining under its buyback authorization. Additionally, HCA maintains $4.336 billion of availability under its credit facility and declared a quarterly dividend of $0.78 per share, payable on June 30 to shareholders of record as of June 16.
π Q1 revenue hit $19.1B, up 4.3% from the prior year.
π Adjusted EBITDA grew 1.9%, though procedure volumes declined slightly.
π° Net income rose 0.6% while EPS increased by 10.9%.
π HCA Healthcare reported Q1 2026 revenue of $19.109 billion, representing a 4.3% increase from the prior year.
π° Net income attributable to the company reached $1.620 billion, an increase from $1.610 billion in the same quarter last year.
π Diluted earnings per share rose 10.9% to $7.15, compared to $6.45 a year ago.
π Adjusted EBITDA grew by 1.9% to $3.802 billion, while cash flow from operating activities surged 22.0%.
π₯ Same-facility admissions increased 0.9%, and same-facility equivalent admissions rose 1.3% during the quarter.
β οΈ Procedure volumes showed weakness with inpatient surgeries down 0.3% and outpatient surgeries falling 1.7%.
π¨ Respiratory-related admissions fell sharply by 42%, and respiratory ER visits declined 32% from the previous year.
π¨οΈ Volume pressures were partly attributed to a January winter storm affecting some markets and reduced respiratory demand.
βοΈ Higher revenue per equivalent admission of 3.1% helped offset volume declines in procedure areas.
π΅ HCA held $940 million in cash, with $48.023 billion in total debt and $61.450 billion in total assets at March 31.
ποΈ Capital expenditures for the quarter totaled $1.119 billion, excluding any acquisitions made during the period.
π The company repurchased 3.157 million shares for $1.571 billion with approximately $9.179 billion remaining in authorization.
π° A quarterly dividend of $0.78 per share was declared, payable on June 30 to shareholders of record June 16.
π Shares dropped -0.76% to $480.32 following the earnings announcement and other financial disclosures.
Bullish Signals
Q1 2026 revenue hit $19.1B with a 4.3% YoY rise.
Net income reached $1.62B while EPS jumped 10.9% to $7.15.
Operating cash flow surged 22% to $2.0B.
Company repurchased 3.2M shares for $1.57B under authorization.
$940M cash on hand ensures strong financial liquidity.
Board declared quarterly dividend of $0.78 per share.
Revenue per admission grew 3.1% showing pricing strength.
Respiratory admissions dropped 42% and ER visits fell 32% QoQ.
High debt load: $48 billion vs $940 million cash.
Revenue growth partly offset by non-core Medicaid programs.
Bullish Signals
HCA Healthcare reported first-quarter 2026 revenue of $19.109 billion, representing a 4.3% year-over-year increase.
Net income attributable to the company rose to $1.620 billion from $1.610 billion, while diluted earnings per share increased 10.9% to $7.15.
Cash flow from operating activities jumped 22.0% to $2.014 billion, demonstrating strong liquidity generation.
The company successfully repurchased 3.157 million shares for $1.571 billion, leaving $9.179 billion remaining under its buyback authorization.
At March 31, HCA held $940 million in cash and cash equivalents, providing a robust financial buffer.
The board declared a quarterly dividend of $0.78 per share, payable to shareholders of record on June 16.
Revenue per equivalent admission increased 3.1% from the prior-year quarter, indicating strong pricing power or mix improvement.
Risk Factors
The market reacted negatively to these announcements, causing shares to decline 0.76% to a price of $480.32.
Procedure volumes weakened significantly, with same-facility inpatient surgeries slipping 0.3% and outpatient surgeries falling 1.7%.
Significant volume pressures were experienced as respiratory-related admissions fell 42% and respiratory-related emergency room visits declined 32% versus the first quarter of 2025.
A January winter storm weighed on volumes in some markets, further suppressing operational metrics.
While revenue per admission increased, it was partly offset by recognizing Medicaid supplemental programs not included in initial 2026 guidance, suggesting reliance on non-core revenue streams to meet targets.
The company held $48.023 billion in total debt against only $940 million in cash and cash equivalents as of March 31, indicating a high leverage position.
Bloomberg journalists analyzed today's major stock market movements, focusing on Intel (INTC), Alphabet (GOOGL), and HCA Healthcare (HCA). Intel shares surged to a record high, reaching $85.22 as of Friday trading in New York, representing a massive 81% gain for the year and marking its first all-time peak since August 2000. This rally followed a sales forecast that significantly exceeded Wall Street expectations, signaling the company's successful turnaround under CEO Lip-Bu Tan despite a challenging period where he faced skepticism about his ability to improve operations after taking the helm in early 2021.
Alphabet (GOOGL) saw its shares rise after announcing a strategic investment of $10 billion in AI-focused company Anthropic PBC at a $350 billion valuation, mirroring the startup's February funding round value. This initial cash commitment comes with an option for Alphabet to invest another $30 billion if specific performance targets are met. The deal solidifies a relationship between partners and rivals in the artificial intelligence sector while supporting a major expansion of Anthropic's computing capacity.
In contrast, HCA Healthcare (HCA) experienced a sharp decline after opting to maintain its yearly guidance for profit and sales despite reporting a strong first quarter. Although the hospital operator beat analyst expectations for first-quarter adjusted earnings at $7.15 per share against an average estimate of $7.10, it decided not to raise its full-year adjusted earnings forecast, which stands between $29.10 and $31.50 per share. Furthermore, HCA's adjusted earnings before interest, taxes, depreciation, and amortization missed estimates, leading to concerns that the company may face headwinds in the coming year despite the current quarter's performance.
π Intel shares hit a record high after exceeding sales forecasts.
π° Alphabet invests $10B in Anthropic amid a massive AI boom.
π Intel shares surged 28% to hit a record high of $85.22 following a sales forecast that exceeded Wall Street expectations.
π€ The chipmaker's strong outlook indicates it is benefiting from a significant boom in AI spending under CEO Lip-Bu Tan.
π° Intel's stock has gained 81% year-to-date, reaching a record level for the first time since August 2000.
π€ Alphabet (Google) committed to investing $10 billion in Anthropic PBC at a $350 billion valuation, with up to $30 billion more potential on performance targets.
β‘ This investment strengthens ties between Google and Anthropic as both partners and rivals in the AI race.
π HCA Healthcare shares fell Friday after the company maintained its annual profit guidance despite beating first-quarter earnings estimates.
πΈ HCA confirmed an adjusted yearly earnings forecast of $29.10 to $31.50 per share for the upcoming fiscal year.
β The hospital operator reported first-quarter adjusted earnings of $7.15, slightly beating analyst expectations of $7.10 per share.
β οΈ HCA downgraded its outlook as adjusted earnings before interest, taxes, depreciation and amortization missed analyst estimates, suggesting future challenges.
Bullish Signals
HCA Healthcare reported first-quarter adjusted earnings of $7.15 a share, beating the average analyst estimate of $7.10 a share.
The company reaffirmed its yearly adjusted earnings forecast, maintaining a range of $29.10 to $31.50 per share.
Risk Factors
HCA Healthcare tumbled after it decided against raising its yearly profit and sales guidance despite first-quarter profit beating analyst views.
The hospital operator reaffirmed a yearly adjusted earnings forecast of $29.10 to $31.50 per share without increasing the upper limit.
HCA reported that first-quarter adjusted EBITDA missed estimates, indicating potential operational challenges later in the year.
HCA Healthcareβs stock fell nearly 9 percent on Friday after the company reported first-quarter earnings that missed Wall Street expectations, despite revenue climbing 4.3 percent to $19.11 billion, which surpassed analyst forecasts. During an earnings call with financial analysts, HCA CEO Sam Hazen explained that specific hospitals in western North Carolina, particularly Mission Health in Asheville, fell slightly behind profit targets primarily due to elevated labor costs. Hazen cited a βsignificant workforce deficitβ at the facility, noting that hundreds of doctors, nurses, and technicians departed since HCA acquired the formerly nonprofit system in 2019. Consequently, Mission Health now relies heavily on traveler and locum staffing to meet demand, with Hazen attributing lower profits to the need to bring in additional labor for nursing and non-nursing roles following higher-than-expected patient volumes driven by illness in the region after Tropical Storm Helene.
Beyond the specific operational challenges at Mission, Hazen and company officials highlighted several broader factors contributing to the missed earnings, including winter storms that delayed surgeries, a seasonal decline in patients with respiratory ailments, and significant impacts from government immigration enforcement on Medicaid applications. The company also pointed to increased insurance denials and a rise in uninsured patients following the expiration of Affordable Care Act subsidies, which drove up premiums and caused many existing subscribers to cancel coverage. Although Hazen stated he frequently travels to Asheville to meet community leaders, this claim was met with skepticism by North Carolina State Sen. Julie Mayfield, who noted she is unaware of any such meetings since 2023 and had previously called for a study on the community impact of HCAβs acquisitions.
The financial miss marks the first time in several years that HCA reported earnings per share below estimates, even as revenue grew to $19.11 billion for the quarter ending March 31, 2026. Hazen acknowledged safety issues at Mission Health during a recent shareholder meeting, referencing multiple citations from state and federal agencies, including two βimmediate jeopardyβ sanctions within the past six months, while refusing to admit that staffing shortages are directly responsible for an alarming number of patient deaths or severe safety violations. HCA currently operates 189 hospitals and approximately 2,600 ambulatory sites across 19 U.S. states and the United Kingdom. The company is facing ongoing scrutiny regarding its labor practices, particularly after Mission Healthβs acquisition in 2019, as they attempt to navigate a complex environment of regulatory compliance, insurance market shifts, and community relations challenges in western North Carolina.
π HCA shares dropped 9% after earnings missed Wall Street estimates.
β οΈ Staffing shortages and winter storms drove up costs at Mission Hospital.
β Safety violations persist despite management denial of staff-related deaths.
π₯ Reliance on travel nurses continues amid a severe workforce deficit.
π§ Company ignored requests for details on CEO's local community meetings.
π HCA Healthcare shares fell nearly 9% after the company reported first-quarter earnings that missed Wall Street expectations.
π° Despite the earnings miss, total revenue for the first quarter rose 4.3% to $19.11 billion compared to the same period last year.
β οΈ CEO Sam Hazen attributed weaker profits at Mission Hospital in North Carolina to higher labor costs and a significant workforce deficit.
π₯ Hundreds of doctors, nurses, and technicians have left Mission since HCA acquired the system in 2019, leading to reliance on travel staff.
πͺοΈ Hazen cited Tropical Storm Helene and increased demand for care as reasons for bringing in additional nursing and non-nursing labor.
π Earnings per share missed estimates for the first time in several years despite strong overall revenue growth.
π¨οΈ Other factors contributing to disappointing earnings included winter storms delaying surgeries and fewer patients with seasonal respiratory ailments.
βοΈ Insurance denials, Medicaid application impacts from immigration enforcement, and an increase in uninsured patients following ACA subsidy expiration also affected results.
π₯ Mission Hospital is the only Level 1 trauma center in western North Carolina but has received multiple safety violations and two "immediate jeopardy" sanctions recently.
π HCA denies that staffing shortages have contributed to patient deaths or severe safety violations at their facilities.
β‘ Hazen called a shareholder proposal supporting a study of community impact by NC State Sen. Julie Mayfield after its second-year defeat at the annual meeting.
β Despite Hazen's claims, local officials express surprise and skepticism about his frequent travels to Asheville to meet with community leaders.
π§ The Asheville Watchdog requested specific dates and names of meetings between Hazen and local stakeholders but received no reply from HCA representatives.
π Mission currently relies heavily on traveler nurses and locum physicians to maintain operations due to the staffing crisis.
β οΈ Management acknowledged they "still have more work to do" regarding safety improvements at Mission Hospital despite receiving multiple awards.
HCA reported $19.11 billion in first-quarter revenue, which was higher than expected despite missing earnings estimates.
The company operates 189 hospitals and approximately 2,600 ambulatory sites of care across 19 states and the United Kingdom, demonstrating significant scale.
CEO Sam Hazen highlighted that Mission Hospital has received multiple awards from ratings services, acknowledging its quality.
HCA's management rejected a shareholder proposal regarding staffing disclosures with significant shareholder support on their side.
Risk Factors
Operating earnings per share missed estimates for the first time in several years despite revenue increasing 4.3% year-over-year.
HCA's shares fell nearly 9% following the report of disappointing financial results.
Mission Hospital relies heavily on traveler nurses and locum physicians due to a significant workforce deficit since HCA's acquisition in 2019, raising concerns about staffing stability.
The facility has received two 'immediate jeopardy' sanctions from state or federal agencies within the past six months for severe safety violations.
Hospital operations face delays caused by winter storms and a reduction in patients suffering from seasonal respiratory ailments.
Government immigration enforcement and insurance coverage denials are contributing to an increase in uninsured patients, negatively impacting Medicaid applications and financial outlook.
Affordable Care Act subsidy expiration has led to soaring premiums and cancelled coverage, further reducing the patient base.
State Sen. Julie Mayfield's shareholder proposal regarding community impact studies failed for the second straight year amid ongoing criticism about HCA's local engagement, as CEO Sam Hazen could not confirm recent visits to Asheville after 2023.
HCA Healthcare reported strong financial performance for the first quarter ended March 31, 2026, with revenues increasing 4.3% year-over-year to $19.109 billion and net income attributable to HCA rising 0.6% to $1.620 billion. Earnings per share and adjusted earnings per share both grew significantly by 10.9% to $7.15 per diluted share, while adjusted EBITDA increased 1.9% to $3.802 billion. Cash flows from operating activities saw a notable 22.0% jump to $2.014 billion, reflecting improved liquidity relative to the previous year's $1.651 billion.
Operational metrics showed resilience despite seasonal headwinds, with same facility admissions up 0.9% and equivalent admissions up 1.3%. However, volumes were impacted by lower respiratory-related activity, which was down 42% in this period, partly due to reduced winter illness and a January winter storm affecting certain markets. Surgical volumes declined slightly, with inpatient surgeries down 0.3% and outpatient procedures falling 1.7%, but revenue per equivalent admission rose 3.1% to offset volume changes. The company repurchased over 3 million shares for $1.571 billion during the quarter, maintaining a remaining authorization of $9.179 billion.
Looking ahead, HCA Healthcare reaffirmed its full-year 2026 guidance previously issued in January. The board declared a quarterly cash dividend of $0.78 per share, payable on June 30, 2026, to shareholders of record as of June 16, 2026. CEO Sam Hazen highlighted the companyβs adaptability in dynamic conditions, and CFO discussions noted that unfavorable respiratory volume impacts were largely offset by newly recognized Medicaid supplemental programs not included in initial guidance. The balance sheet remains robust with $940 million in cash equivalents and $48.023 billion in total debt.
π Revenue rose 4.3% to $19.1B despite a 42% respiratory volume drop.
π° Operating cash flow surged 22%, while net income grew 0.6%.
πΈ Company repurchased shares worth $1.57B and raised quarterly dividend.
π Revenue grew 4.3% year-over-year to $19.109 billion in Q1 2026.
π° Net income increased 0.6% to $1.620 billion, with EPS rising 10.9% to $7.15.
π Adjusted EBITDA grew 1.9% to $3.802 billion as a key non-GAAP financial metric.
The company repurchased 3.157 million shares at a cost of $1.571 billion and maintains $9.179 billion in remaining repurchase authorization.
HCA Healthcare declared a quarterly cash dividend of $0.78 per share to be paid on June 30, 2026.
The company reaffirmed its 2026 estimated guidance, signaling management confidence in future performance despite headwinds.
Unfavorable volume impacts were successfully offset by the recognition of certain Medicaid supplemental programs not included in initial guidance.
Risk Factors
During the first quarter of 2026, HCA Healthcare did not experience a typical seasonal volume increase due to respiratory activity, with respiratory-related admissions dropping 42% and emergency room visits down 32% compared to the prior year.
A winter storm in January negatively impacted first quarter volumes in certain markets, further depressing operational metrics during the reporting period.
Same facility inpatient surgeries declined 0.3% while same facility outpatient surgeries declined 1.7%, indicating headwinds in elective or procedure-based care volumes despite overall revenue growth.
The company's forward-looking guidance explicitly excludes significant potential risks such as legal claims costs, impairment of long-lived assets, and losses on debt retirement or sales of facilities, introducing uncertainty to future earnings stability.
Future dividend payments are subject to Board discretion and depend on financial condition rather than being guaranteed, suggesting a lack of committed cash distribution beyond the current quarter.
Guidance assumptions rely on an anticipated mostly stable operating environment and stable payer mix, which could be disrupted by health care public policy developments or administrative reforms.
The expiration of enhanced premium tax credits and estimated impacts from administrative reforms are factored into guidance but present external regulatory headwinds that could alter reimbursement dynamics.
HCA Healthcare, Inc. presented at the Leerink Global Healthcare Conference on March 10, 2026, with Chief Financial Officer Mike Marks and Erol Akdamar, who oversees the American Group comprising nearly 70 hospitals including significant operations in Texas. The company's leadership emphasized that artificial intelligence and digital transformation represent a core strategic initiative designed to drive growth through the decade ahead. A central component of this strategy is the implementation of MEDITECH Expanse, a cloud-native electronic health record system currently deployed at just under 50 hospitals. Management projects that this rollout will be completed by the end of 2028, citing it as their most significant project in terms of resources and effort throughout company history.
The MEDITECH Expanse platform is intended to establish a robust foundation for HCA by enabling more standardized data management and improved workflow capabilities. This digital agenda serves as the first part of a multi-faceted approach to future growth, aiming to enhance operational efficiency across the network. While specific financial metrics or valuation guidance were not detailed in this excerpt, the focus remained on the execution timeline and strategic importance of digitizing hospital operations. Erol Akdamar's role extends beyond the American Group, though his specific portfolio size was noted as encompassing nearly 70 facilities across the U.S., underscoring the scale at which these digital initiatives are being implemented to prepare the organization for future challenges and opportunities in the healthcare landscape.
HCA presented at Leerink Conference on March 10, led by CFO Mike Marks.
Erol Akdamar leads the American Group with nearly 70 hospitals including Texas.
Digital transformation and AI are key growth strategies for the next decade.
MEDITECH Expanse is live at under 50 hospitals with completion expected end-2028.
Cloud-native platform upgrade aims to standardize data management and enhance workflows.
ποΈ HCA Healthcare presented at the Leerink Global Healthcare Conference on March 10, 2026.
πΌ The executive team featured Mike Marks as CFO and Erol Akdamar leading the American Group with nearly 70 hospitals.
π₯ Erol Akdamar oversees a portfolio including the important Texas market among other locations.
π± Digital transformation and AI are identified as key strategic initiatives to drive growth over the next decade.
π» The MEDITECH Expanse rollout is currently live at just under 50 hospitals.
β³ Management expects the MEDITECH Expanse project to be fully wrapped up by the end of 2028.
π This system upgrade is described as the biggest project in company history regarding resources and effort.
βοΈ The new MEDITECH platform is cloud native and aims to standardize data management across facilities.
βοΈ The technology will enhance capabilities for managing workflows and master files.
Bullish Signals
MEDITECH Expanse rollout launched at ~50 hospitals, targeting completion by late 2028.
Digital transformation named a key strategic priority to drive decade-long performance.
Cloud-native architecture enables standardized data, workflow, and master file control.
Risk Factors
Biggest project diverts resources from other initiatives.
Timeline extends to 2028, creating long-term execution risk.
Fewer than 50 hospitals adopted system; adoption may delay gains.
Heavy AI investment burdens capital expenditure and impacts margins.
Transcript cuts off before clarifying realized benefits or challenges.
70 hospitals in American Group requires multi-year rollout coordination.
Bullish Signals
The MEDITECH Expanse rollout is now live at just short of 50 hospitals and is on track to be completed by the end of 2028.
This digital transformation initiative is described as one of the company's key strategic initiatives to propel performance over the rest of the decade.
The MEDITECH Expanse project is cloud native, providing capabilities for more standardized data, workflow management, and master file control.
Risk Factors
The MEDITECH Expanse rollout is described as the biggest project in the company's history, indicating significant resource allocation and operational focus that could divert attention from other initiatives.
The implementation timeline extends until the end of 2028, representing an extended period of ongoing uncertainty and execution risk for such a major digital transformation effort.
Only just short of 50 hospitals have adopted the system so far, suggesting a gradual adoption pace that may delay anticipated efficiency gains over the next several years.
Heavy investment in AI and digital transformation is highlighted as a key strategic initiative, which raises questions about near-term capital expenditure burdens and potential impact on margins during this transition period.
The transcript cuts off while discussing capabilities related to standardizing data and managing workflows, leaving unclear whether full benefits have been realized or if challenges remain unresolved.
With nearly 70 hospitals in the American Group (including the Texas market), completing the rollout across all locations will require substantial time and coordination over a multi-year period.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)